DHR
32
-6
DE
42
3
NOV
52
-5
PYPL
52
-2
JBHT
56
-3
ORLY
60
-5
TROW
47
-6
STI
45
26
CAG
24
-3
SE
60
-3
PBI
56
-2
UNH
57
-2
BBY
52
6
TXT
53
-3
RL
69
-4
DAL
84
-3
GRMN
67
-4
MRO
50
4
ILMN
32
-9
VNO
46
-13
DHR
32
-6
DE
42
3
NOV
52
-5
PYPL
52
-2
JBHT
56
-3
ORLY
60
-5
TROW
47
-6
STI
45
26
CAG
24
-3
SE
60
-3
PBI
56
-2
UNH
57
-2
BBY
52
6
TXT
53
-3
RL
69
-4
DAL
84
-3
GRMN
67
-4
MRO
50
4
ILMN
32
-9
VNO
46
-13
Financhill
Back

FlexShares ESG&Clmt Invm Grd Corp Cr Idx Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
63

FEIG
FlexShares ESG&Clmt Invm Grd Corp Cr Idx

Last Price:
40.91
Seasonality Move:
0.85%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
63
FlexShares ESG&Clmt Invm Grd Corp Cr Idx (FEIG) is a Buy

Is FlexShares ESG&Clmt Invm Grd Corp Cr Idx a Buy, Sell or Hold?

  • The current FlexShares ESG&Clmt Invm Grd Corp Cr Idx [FEIG] share price is $40.96. The Score for FEIG is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • FEIG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FEIG Stock Price Chart

What is FlexShares ESG&Clmt Invm Grd Corp Cr Idx's stock price today?

  • The FlexShares ESG&Clmt Invm Grd Corp Cr Idx share price today is $40.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FEIG is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

FEIG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 5183 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.01 - 41.65) Sell
Bollinger Bands (100): (40.98 - 42.16) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

FEIG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.1 Sell
20-day SMA: 41.19 Sell
50-day SMA: 41.8 Sell
200-day SMA: 41.1 Sell
8-day EMA: 41.06 Sell
20-day EMA: 41.24 Sell
50-day EMA: 41.51 Sell
200-day EMA: 41.21 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

FlexShares ESG&Clmt Invm Grd Corp Cr Idx Earnings Growth & FEIG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

FlexShares ESG&Clmt Invm Grd Corp Cr Idx Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):